logo

MYGN

Myriad GeneticsยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --

MYGN Profile

Myriad Genetics, Inc.

A leader in genetic testing and precision medicine

Biological Technology
--
10/06/1995
NASDAQ Stock Exchange
2,700
12-31
Common stock
322 North 2200 West, Salt Lake City, UT 84116
--
Myriad Genetics, Inc., is a Delaware corporation. The company is a leading genetic testing and precision medicine company dedicated to promoting the health and well-being of all people. The company provides insights that help people take control of their health and enable health care providers to better detect, treat and prevent disease. The company develops and provides tests that help assess the risk of disease or disease progression and guide treatment decisions across medical specialties where genetic insights can significantly improve patient care and reduce healthcare costs.